evaluate the pharmaceuticals and biotechnology company novo nordisk on glp-1's Nordisk, GLP-1s, Alzheimer's: Readout Newsletter Novo and Lilly battle over

Insulin-Like Growth Factor 1: At the Crossroads of Brain Development and Aging

But doctors say comparing the two is like comparing apples and oranges

WHO and EMA Warnings About Semaglutide and NAION In June 2025, the World Health Organization alerted healthcare professionals and regulatory authorities to the risk of non-arteritic anterior ischemic optic neuropathy (NAION) associated with semaglutide medications, including Ozempic, Rybelsus, and Wegovy

Getting popular peptides reclassified as category one would be a big deal, Husain says

In parallel, Ipamorelin activation of GHSR-1a initiates Gq-mediated signaling that elevates intracellular calcium levels, promoting vesicular secretion of growth hormone